BI 1323495
Sponsors
Boehringer Ingelheim
Conditions
HealthyNon-cystic Fibrosis Bronchiectasis
Phase 1
This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.
CompletedNCT03588390
Start: 2018-07-31End: 2018-11-14Updated: 2024-02-22
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1323495 in the Blood
CompletedNCT04011241
Start: 2019-07-24End: 2019-09-06Updated: 2024-02-22
A Study in Healthy Men and Women to Test How Well Different Doses of BI 1323495 Are Tolerated
CompletedNCT04107805
Start: 2019-11-04End: 2021-03-26Updated: 2024-02-22
A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood
CompletedNCT04619251
Start: 2020-11-13End: 2021-08-03Updated: 2024-03-27
A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation
TerminatedNCT04656275
Start: 2021-03-04End: 2022-01-19Updated: 2024-11-27